from Stocks-Markets-Economic Times https://ift.tt/2KxiARt
Home »
Stocks-Markets-Economic Times
» India likely to approve AstraZeneca vaccine by next week: Sources
India likely to approve AstraZeneca vaccine by next week: Sources
from Stocks-Markets-Economic Times https://ift.tt/2KxiARt
Related Posts:
UltraTech reports a 114% jump in PAT at Rs 1,703 in Q1Net sales at the Aditya Birla Group flagship climbed 54 per cent to Rs 11,698 crore, fuelled by pent-up demand and a low statistical base. It recorded a volume growth of 48 per cent. from Stocks-Markets-Economic Times https:… Read More
Wendt India Q1 results: Co reports consolidated PAT at Rs 6 croreFor the financial year ending March 31, 2021, consolidated PAT was at Rs 12.77 crore, Wendt India said in a statement. from Stocks-Markets-Economic Times https://ift.tt/3eQ3Nx8 … Read More
Yes Bank Q1 profit quadruples as NPA additions slowProfits were helped by a 70 per cent growth in non-interest income to Rs 1056 crore up from Rs 621 crore a year ago which included fees from retail and corporate banking, forex, debt capital markets and recoveries from writte… Read More
NSE-BSE bulk deals: Ashish Kacholia sells stake in Apollo PipesIn another transaction, HDFC Bank sold 20,000 shares of Indo-National at Rs. 1,088.2 apiece through a bulk deal on the NSE. from Stocks-Markets-Economic Times https://ift.tt/3zqZa4s … Read More
JSW Steel reports Rs 5,900 crore of PAT in Q1 of FY 22Revenue from operations more than doubled to Rs 28, 902 crore as against Rs 11,782 crore. JSW Steel’s total expenses were at Rs 20,804 crore, up 66% year-on-year. from Stocks-Markets-Economic Times https://ift.tt/3rxCA7n … Read More
0 Comments:
Post a Comment